AFIB (Acutus Medical) Additional Paid-In Capital: $598.67 Mil(As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acutus Medical Additional Paid-In Capital?

Acutus Medical AFIB Additional Paid-In Capital is $598.67 Mil as of Dec. 2024.


Acutus Medical's quarterly additional paid-in capital increased from Jun. 2024 ($598.54 Mil) to Sep. 2024 ($598.67 Mil) but then stayed the same from Sep. 2024 ($598.67 Mil) to Dec. 2024 ($598.67 Mil).

Acutus Medical's annual additional paid-in capital increased from Dec. 2022 ($594.17 Mil) to Dec. 2023 ($599.94 Mil) but then declined from Dec. 2023 ($599.94 Mil) to Dec. 2024 ($598.67 Mil).

Acutus Medical Additional Paid-In Capital Related Terms

Acutus Medical Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Acutus Medical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acutus Medical Additional Paid-In Capital Chart

Acutus Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 487.29 584.61 594.17 599.94 598.67

Acutus Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 599.94 598.41 598.54 598.67 598.67

Acutus Medical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of $598.67 Mil mean?
Acutus Medical (AFIB) has a Additional Paid-In Capital of $598.67 Mil as of Dec. 2024. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Acutus Medical and its competitors.
Is Acutus Medical's Additional Paid-In Capital too high?
Acutus Medical's current Additional Paid-In Capital is $598.67 Mil.
How does Acutus Medical's Additional Paid-In Capital compare to DHAI and ABT?
Acutus Medical's Additional Paid-In Capital of $598.67 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Medical Devices & Instruments company?
A good Additional Paid-In Capital depends on the Medical Devices & Instruments industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Acutus Medical and its competitors. Acutus Medical's current Additional Paid-In Capital is $598.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutus Medical stock overvalued right now?
Acutus Medical (AFIB) has a current Additional Paid-In Capital of $598.67 Mil. The current Additional Paid-In Capital is $598.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Acutus Medical (AFIB), the current Additional Paid-In Capital is $598.67 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acutus Medical Business Description

Address 2210 Faraday Avenue, Suite 100, Carlsbad, CA, USA, 92008
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products world-wide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.